195 related articles for article (PubMed ID: 1713139)
21. Prognostic impact of uncertain parietal pleural invasion at adhesion sites in non-small cell lung cancer patients.
Mikubo M; Nakashima H; Naito M; Matsui Y; Shiomi K; Jiang SX; Satoh Y
Lung Cancer; 2017 Jun; 108():103-108. PubMed ID: 28625620
[TBL] [Abstract][Full Text] [Related]
22. Invasive staging of non-small cell lung cancer--a prospective study.
Eggeling S; Martin T; Böttger J; Beinert T; Gellert K
Eur J Cardiothorac Surg; 2002 Nov; 22(5):679-84. PubMed ID: 12414030
[TBL] [Abstract][Full Text] [Related]
23. Management of clinical stage IIIA primary lung cancers in the National Cancer Database.
Hancock J; Rosen J; Moreno A; Kim AW; Detterbeck FC; Boffa DJ
Ann Thorac Surg; 2014 Aug; 98(2):424-32; discussion 432. PubMed ID: 24929895
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of multi-level N2-positive non-small cell lung cancer according to lymph node staging using endobronchial ultrasound-transbronchial biopsy.
Yoon HY; Lee JC; Kim SW; Kim HR; Kim YH; Choi SH; Kim SS; Song SY; Choi EK; Jang SJ; Choi CM
Thorac Cancer; 2018 Jun; 9(6):684-692. PubMed ID: 29607613
[TBL] [Abstract][Full Text] [Related]
25. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
26. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
27. [Treatment outcome of locally advanced stage IIIA/B lung cancer].
Cicenas S; Zaliene A; Atkocius V
Medicina (Kaunas); 2009; 45(6):452-9. PubMed ID: 19605965
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
29. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of fine needle aspiration cytology in the pathological typing of non-small cell lung cancer.
Nizzoli R; Tiseo M; Gelsomino F; Bartolotti M; Majori M; Ferrari L; De Filippo M; Rindi G; Silini EM; Guazzi A; Ardizzoni A
J Thorac Oncol; 2011 Mar; 6(3):489-93. PubMed ID: 21258246
[TBL] [Abstract][Full Text] [Related]
31. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
32. Special treatment issues in non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Kozower BD; Larner JM; Detterbeck FC; Jones DR
Chest; 2013 May; 143(5 Suppl):e369S-e399S. PubMed ID: 23649447
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical analysis of C/EBPalpha in non-small cell lung cancer reveals frequent down-regulation in stage II and IIIA tumors: a correlative study of E3590.
Costa DB; Li S; Kocher O; Feins RH; Keller SM; Schiller JH; Johnson DH; Tenen DG; Halmos B
Lung Cancer; 2007 Apr; 56(1):97-103. PubMed ID: 17239984
[TBL] [Abstract][Full Text] [Related]
34. Utility of blind forceps biopsy of the main carina and upper-lobe carina in patients with non-small cell lung cancer.
Gunen H; Kizkin O; Tahaoglu C; Aktas O
Chest; 2001 Feb; 119(2):632-7. PubMed ID: 11171748
[TBL] [Abstract][Full Text] [Related]
35. Docetaxel as second-line chemotherapy for advanced non-small cell lung cancer.
Thongprasert S; Cheewakriangkrai R; Napapan S
J Med Assoc Thai; 2002 Dec; 85(12):1296-300. PubMed ID: 12678167
[TBL] [Abstract][Full Text] [Related]
36. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer.
Chansky K; Sculier JP; Crowley JJ; Giroux D; Van Meerbeeck J; Goldstraw P;
J Thorac Oncol; 2009 Jul; 4(7):792-801. PubMed ID: 19458556
[TBL] [Abstract][Full Text] [Related]
37. Adequacy of endobronchial ultrasound transbronchial needle aspiration samples in the subtyping of non-small cell lung cancer.
Esterbrook G; Anathhanam S; Plant PK
Lung Cancer; 2013 Apr; 80(1):30-4. PubMed ID: 23312886
[TBL] [Abstract][Full Text] [Related]
38. Outcome of Patients With pN2 "Potentially Resectable" Nonsmall Cell Lung Cancer Who Underwent Surgery After Induction Chemotherapy.
Spaggiari L; Casiraghi M; Guarize J; Brambilla D; Petrella F; Maisonneuve P; De Marinis F
Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):593-602. PubMed ID: 28043483
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
Elias AD; Skarin AT; Leong T; Mentzer S; Strauss G; Lynch T; Shulman L; Jacobs C; Abner A; Baldini EH; Frei E; Sugarbaker DJ
Lung Cancer; 1997 May; 17(1):147-61. PubMed ID: 9194034
[TBL] [Abstract][Full Text] [Related]
40. Plasma DNA, microsatellite alterations, and p53 tumor mutations are associated with disease-free survival in radically resected non-small cell lung cancer patients: a study of the perugia multidisciplinary team for thoracic oncology.
Ludovini V; Pistola L; Gregorc V; Floriani I; Rulli E; Piattoni S; Di Carlo L; Semeraro A; Darwish S; Tofanetti FR; Stocchi L; Mihaylova Z; Bellezza G; Del Sordo R; Daddi G; Crinò L; Tonato M
J Thorac Oncol; 2008 Apr; 3(4):365-73. PubMed ID: 18379354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
